McKesson (MCK) Laps the Stock Market: Here's Why
The latest trading day saw McKesson (MCK) settling at $591.07, representing a +1.07% change from its previous close.
Is Trending Stock McKesson Corporation (MCK) a Buy Now?
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
McKesson (MCK) Gains 26% YTD: What's Driving the Rally?
McKesson's (MCK) shares have risen year to date on the back of strong fundamentals. Rising volumes of prescription and specialty drugs boost the top line.
McKesson is a Growing Giant
McKesson Corporation (MCK) is poised to grow due to an aging population and expanding Type 2 diabetes treatments.
Here's Why You Should Hold McKesson (MCK) in Your Portfolio Now
McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
Why McKesson (MCK) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Bulletproof Your Retirement: 3 Stocks That Will Stand the Test of Time
In retirement, stability and downside protection are the main investment objectives. You need retirement-proof stocks that guarantee stable growth with minimal volatility to succeed.
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now?
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
Here's Why McKesson (MCK) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
